MapLight Therapeutics, Inc.

Direct answer

MapLight Therapeutics, Inc. is publicly traded on NASDAQ under the ticker MPLT.

MapLight Therapeutics, Inc. is a clinical-stage biopharmaceutical firm dedicated to developing innovative treatments for individuals grappling with severe central nervous system (CNS) disorders. Its pipeline features several promising therapeutic candidates: ML-007C-MA, a fixed-dose combination of an M1/M4 muscarinic agonist, is being advanced to address symptoms of schizophrenia and Alzheimer's disease psychosis....

Can you invest in MapLight Therapeutics, Inc.?

Yes. MapLight Therapeutics, Inc. trades publicly on NASDAQ as MPLT.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for MapLight Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.